Navigation Links
Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout
Date:7/9/2008

-- Dr. Fernando Perez-Ruiz Joins Ardea's Inflammatory Disease Scientific

Advisory Board --

SAN DIEGO, July 9 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced that it has received regulatory approval to begin a Phase 2a proof-of-concept clinical trial evaluating RDEA806 in gout patients with hyperuricemia. Gout, also known as metabolic arthritis, is a painful and debilitating disease caused by abnormally elevated levels of uric acid in the blood stream, and is the most common form of inflammatory arthritis in men over 40. The Company also announced that gout specialist, Dr. Fernando Perez-Ruiz in Spain, will be the newest member of its inflammatory disease scientific advisory board (SAB).

Ardea previously announced the designation of RDEA594, a major metabolite of RDEA806, the Company's lead human immunodeficiency virus (HIV) development compound, as its lead development candidate for the treatment of patients with gout. RDEA594 does not have antiviral activity, but is believed to be responsible for essentially all of the uric acid lowering effects seen with RDEA806. Uric acid lowering effects have been observed following administration of RDEA806 in Phase 1 and Phase 2 clinical trials that included over 100 subjects.

"The Phase 2a trial should allow us to confirm RDEA594's activity in the target population of patients with gout using its prodrug, RDEA806. Enrollment in the Phase 2a trial should begin shortly and we are on track to initiate a Phase 1 trial with RDEA594 in the second half of this year," said Barry D. Quart, PharmD, Ardea Biosciences' President and CEO. "We also are extremely pleased to add Dr. Fernando Perez-Ruiz to our inflammatory diseases S
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Craig Johnson Joins Ardea Biosciences Board of Directors
2. Ardea Biosciences Presents Inflammation Program Data for Arthritis and Gout at 2008 Annual European Congress of Rheumatology
3. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008
4. Ardea Presents Preclinical Data on Novel Next Generation Non-Nucleoside Reverse Transcriptase Inhibitors Demonstrating Potent Anti-HIV Activity Against Resistant Viruses
5. Ardea to Present Data on HIV Non-Nucleoside Reverse Transcriptase Inhibitor and Two MEK Inhibitors at Upcoming Medical Conferences
6. Ardea to Present at Cowen and Companys 28th Annual Health Care Conference
7. Ardea Biosciences to Move Headquarters and R&D Laboratories to San Diego
8. Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program
9. Ardea Biosciences to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
10. Ardea Biosciences Establishes Scientific Advisory Board for HIV Program
11. Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Nov. 25 Reportlinker.com announces... its catalogue: ,, Brazil Bioethanol Market An...portlinker.com/p0165503/Brazil-Bioethanol-Market-A...ioethanol Market Analysis and Forecasts to 2013 ,...nalysis and forecasts of the global bioethanol mar...
(Date:11/24/2009)...bassador to also Visit Detroit , ...id Appia, French Ambassador for International Inve...ce Agency, , , , ,What: Ambassador Appia is avail...ness initiatives adopted by France to further deve...or innovation and development., , ,When: Available...
(Date:11/24/2009)... REYKJAVIK, Iceland, November 24 /PRNewswire-First...ay announced that it has received notice from,the ...common stock will be,suspended as of November 30, ...rities and Exchange Commission, which will remove ...ss the company files an appeal to the Nasdaq,Listi...
(Date:11/24/2009)... Nov. 24 /PRNewswire-Asia/ -- NOD Pharmaceuticals ...e (PTO) has allowed the patent application for,its..., NOD technology is a highly efficient appr...adhesive nano-particles to enable oral delivery of...echnology is a platform technology,that can be app...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
... mammals, the protective shells of mollusks, and t...rine creatures are made-from-scratch wonders of na...t and for defense, the materials of which shells, ... most durable in the animal world, and scientists ...ow, harnessing the process of biomineralization ma...
...ER 4, 2008, SAN DIEGO, Oct. 27 Neurocrine Biosci...evin Gorman, President and Chief,Executive Officer...he,Oppenheimer 19th Annual Healthcare Conference i...esday, November 4, 2008 at 10:00,a.m. Eastern Time...on will,be simultaneously webcast and may be acces...
...earch Group, Inc. was,named one of the 2007 Top 10...e Philadelphia region by the Philadelphia 100(R), ...lopment Center, the Entrepreneurs, Forum of,Greate...nal. The rankings,are based on verifiable revenue ...uniqueness of our business,model and the value tha...
Other Biology Technology:Sea urchin yields a key secret of biomineralization 2Sea urchin yields a key secret of biomineralization 3Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference 2
(Date:11/24/2009)...dical Toxicology (ACMT) have signed an agreement t...f Medical Toxicology (JMT), the official journal ...iously published by the University of Pennsylvania...an international, peer-reviewed journal, is dedica...al toxicology. The quarterly journal focuses on t...
(Date:11/24/2009)... research on bacterial communities throughout six ...temporal patterns, suggesting that scientists coul...climate change in the polar regions. The study, pu...nal Academy of Sciences Early Edition, shows that...ynchronously over time, correlating with seasonal ...
(Date:11/23/2009)... Applied mathematicians dissected the morphology ...cteristic long leaf with a saddle-like arc midsect...e simple cause of the lily,s fan-like shapeelastic...tial growthwas revealed by using an equally simple...ng, a postdoctoral student at Harvard,s School of ...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2The cause behind the characteristic shape of a long leaf revealed 2More Mammograms May Mean More Harmless Cancers 51316 1More Mammograms May Mean More Harmless Cancers 51316 2Team Develops Anti Infection Technology 51311 1Team Develops Anti Infection Technology 51311 2Insightful Handbook for Alzheimers Caregivers 51306 1Insightful Handbook for Alzheimers Caregivers 51306 2Insightful Handbook for Alzheimers Caregivers 51306 3
...lifornia, San Diego, offer a new explanation for a...als found along the Malay Peninsula in southeast A...he absence of any geographical barrier. , An anci...daman Sea was once thought have split the peninsul...s to diverge. But a recent revision of the history...
...lobe dementia (Frontotemporal Dementia, FTD) strik...ease, FTD is the form of dementia that occurs most...he disease process starts in the frontal lobe wher...he frontal lobe is the foremost part of the brain ...r things, it is involved in regulating behavior, m...
...eers J. Craig Venter, Energy Bioscience Institute,...l highlight the U.S. Department of Energy Joint Ge... and Environment User Meeting March 25-27, 2009 in... emphasize the genomics of renewable energy strate...l gene discovery, and engineering of fuel-producin...
Other Biology News:New explanation for a puzzling biological divide along the Malay Peninsula 2Blood test predicts chance of dementia 2Venter, Somerville and Church highlight DOE/JGI genomics of energy and environment meeting 2
...a complete assay system for the measurement of 1,2...asma. The assay incorporates the same award-winnin...IA followed by quantitation by convenient enzymeim...nts, no organic or solvent waste disposal is requi...
Rabbit Anti-Nck alpha Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Drosophila Melanogaster Achaete protein Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Rabbit Anti-Human ABCD4 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Biology Products: